Navigation Links
Joyant-Licensed Technology Earns Broad Patent Protection

DALLAS, Feb 15, 2011 /PRNewswire/ -- Joyant Pharmaceuticals Inc. ("Joyant"), a privately-held pharmaceutical company, announced the grant of an exceptional US patent covering an entire class of anti-cancer therapeutics based upon Smac mimetics.  Smac mimetics represent a novel approach to targeting the apoptotic pathway and have broad potential for the treatment of cancer, both solid tumor and hematological malignancies.

The United States Patent and Trademark Office (USPTO) granted US Pat. No. 7,884,211 on Joyant's exclusively-licensed anticancer drug technology.  "The USPTO issues broad claims like this only for truly pioneering inventions," noted Richard Aron Osman, JD, PhD, of the Science and Technology Law Group, the patent attorney responsible for prosecuting the patent application.

"Smac" is a natural protein that triggers the destruction of cancer cells. Researchers at UT Southwestern Medical Center serendipitously discovered that dimeric small molecule Smac mimics are extremely effective killers of cancer cells.  Joyant Pharmaceuticals, the exclusive licensee of this UT Southwestern technology, is actively developing Smac mimetics as anti-cancer therapeutics.

"We are very pleased with the scope of this issued patent.  It is a testament to the innovation and potential in our Smac mimetic program," said Dr. Lai Wang, Director of Research at Joyant.

"It is one of our most promising development platforms, with outstanding lead compounds."

About Joyant

Joyant Pharmaceuticals is a Dallas-based drug discovery company focused on the development of small molecule therapeutics for cancer. Joyant is actively translating the molecular pathways that control the growth, replication, and apoptosis of human cells into signaling-based targeted therapeutics.  Joyant has the financial backing of Sanderling Ventures.

SOURCE Joyant Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Proventix Helps Princeton Baptist Medical Center Earn National Recognition from HIMSS/ASQ for Quality Improvement Using Information Technology
2. Reportlinker Adds Global Anti-counterfeit Markets in Food & Pharmaceutical Applications by Geography, Technology Trends and Forecasts (2010-2015)
3. DSM Biologics Reports a New Record Achievement with DSMs Proprietary XD® Process Technology with a CHO Cell Line Producing an Fc-fusion Protein:
4. Abbotts Ibis Technology Identified Fatal Disease Organism in Afghanistan
5. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
6. Endologix Announces Favorable Clinical Results for Nellix Technology
7. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
8. US Army Study Shows STB Lifesaving Technologys® FAST® Dressing Superior to the Most Effective Currently Available Agents for Controlling Arterial Bleeding
9. Weikang Bio-Technology Announces Inclusion of Ranitidine Hydrochloride Capsule on National Drug Reimbursement List
10. Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
11. Crestwood Technology Group Receives Silver Boeing Performance Excellence Award
Post Your Comments:
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "2016 Future ... Drugs of Abuse Testing Market: Supplier Shares, ... report to their offering. --> ... of the "2016 Future Horizons and ...
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ( ... "Advanced Wound Care Market by Type (Dressings, Therapy Devices, ... (In-Patient Facility, Out-Patient Facility), and Geography - Global Forecast ... --> --> The purpose ... and forecast of the global advanced wound care market. ...
(Date:11/26/2015)... Research and Markets ( ) ... Future Horizons and Growth Strategies in the Italian ... Segment Forecasts, Competitive Intelligence, Emerging Opportunities" report ... --> This new 247-page report ... drug monitoring market, including emerging tests, technologies, instrumentation, ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... The print component ... Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of ... distributed nationally, through a vast social media strategy and across a network of ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed ... 1-1 ). More than 3.7 billion people under the age of 50 – or ... to WHO's first global estimates of HSV-1 infection . , "The data shocks us ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official ... independent group of Microsoft Dynamics SL software users, partners, industry experts and representatives. ...
(Date:11/27/2015)... Minn. (PRWEB) , ... November 27, 2015 , ... ... start failing. Secura Consultants has prided itself for not only fulfilling the needs ... income protection solutions at an affordable price and providing top-tier customer service. However, ...
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... Commission on Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic ... list of CAAHEP accredited colleges, as only one of twelve colleges and universities in ...
Breaking Medicine News(10 mins):